LOWER RESPIRATORY DISORDERS REP 21 Flashcards
(24 cards)
LOWER RESPIRATORY DISORDERS
Anatomy & Physiology
Trachea
Bronch
Lungs
Alveoli
Types of COPD:
- progressive lung disease caused by smoking or chronic lung infection
Chronic bronchitis
Types of COPD:
- dilation of the bronchi and bronchioles is abnormal secondary to frequent
infection and inflammation, “blue bloaters”
Bronchiectasis
Types of COPD:
- progressive lung disease caused by cigarette smoking, atmospheric
contaminants, “pink puffers”
Emphysema
Types of COPD:
- inflammatory disorder of the airway walls associated with a varying amount of
airway obstruction, with wheezing
Asthma
Mast cells stimulate the release of chemical mediators
(histamines, cytokines,
serotonin, eosinophil factor of anaphylaxis (ECF-A), and leukotrienes.
Cyclic adenosine monophosphate (cyclic AMP, or CAMP)
- maintain
bronchodilation
Albuterol
l
● treatment and control of asthma by bronchodilation with long duration of
action
SE: restlessness, tremors, palpitations
*Overuse may cause beta 1 response such as nervousness, tremor and
increased pulse rate.
Anticholinergics
Methylxanthine -
- bronchodilators used to treat asthma is the methylxanthine (xanthine)
examples: aminophylline, theophylline, and caffeine
SE AR: nausea, vomiting, gastric pain, bleeding, dysrhythmias
Anticholinergics
Theophylline
- relaxes the smooth muscles of the bronchi, bronchioles, and pulmonary
blood vessels by inhibiting the enzyme phosphodiesterase, resulting in an increase in cAMP,
which promotes bronchodilation.
Theophylline
range
side effects
therapeutic range is 5-15 mcg/mL
:20 mcg/mL
cause hyperglycemia, decreased clotting time, and, rarely, leukocytosis
avoid caffeinated products
Anticholinergics
Leukotriene Receptor Antagonists and Synthesis Inhibitors
Leukotriene Receptor
Antagonist
Zafirlukast (Accolate)
prophylaxis and maintenance therapy for chronic asthma and
inflammation within bronchial airways
Emphasis: It is used to prevent but not to treat active asthma
Combination Drug:
Glucocorticoid and
Beta-2 Agonist
Fluticasone Propionate
and Salmeterol
asthma but not to treat acute asthmatic attack .
● long-term maintenance of COPD including bronchitis and
emphysema
Glucocorticoids (Steroids) – treat asthma
- act as an anti-inflammatory agent.
Can be given using the following methods:
be given using the following methods:
● MDI inhaler: Beclomethasone
● Tablet: Dexamethasone, Prednisone
● Intravenous: Dexamethasone
➔ Inhaled glucocorticoids are ineffective vs severe asthmatic attacks because
they take 1-4 weeks to reach full effect
Cromolyn Sodium
(Gastrocrom)
chronic and prophylactic use, suppresses inflammation in bronchial
tubes and prevents release of histamines
● maintenance therapy in mild to moderate asthma and suppress
release of histamine
Glucocorticoids (Steroids)
– treat asthma
- act as an anti-inflammatory agent.
3 S of Steroids:
Salt Mineralocorticoids – Aldosterone – water retention – ↑ BP
Sex Androgens – sex hormone
Sugar Glucocorticoids – cortisol – increased blood sugar
Emphasize the 3S: that will remind students of the side effects of steroids
Cromolyn (Cromolyn sodium)
- prophylactic treatment of bronchial asthma. Cromolyn
- must be taken daily
- inhibits the release of histamine and inflammatory mediators from mast cells.
Drug Therapy for Asthma According to Age
Young Children
- Cromolyn - is used to treat inflammatory effects of asthma in children.
- Oral glucocorticoids - to control a moderate to severe asthmatic state.
➢ An inhalation dose should be about 1 to 2 inhalations 4 times a day. - Oral Beta2-adrenergic agonists - for severe conditions of asthma in selected young
children.
Older Adults
Beta2-adrenergic agonists and methylxanthines such as theophylline can
cause:
● Tachycardia – COMMON!
● Nervousness
● Tremors
Frequent use of glucocorticoids can increase risk of developing:
● Cataracts
● Osteoporosis
● Diabetes mellitus
Mucolytics
Act as detergent to liquefy and loosen thick, mucous secretions so they can be
expectorated
Mucolytics
Acetylcysteine
- is administered by nebulization for bronchopulmonary disorders.
Mucolytics
Dornasa Alfa
enzyme that digests DNA in thick sputum secretions of patients with
cystic fibrosis
❖ Helps reduce respiratory infections and improve
pulmonary functions.
❖ Improvement usually occurs in 3 to 7 days with its use.
❖ SE: chest pain, sore throat, laryngitis and hoarseness.